Illumina, Inc. Signs Master Supply Agreement To Provide Next-Generation Sequencing Technologies To LabCorp®
Published: Jan 21, 2014
SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN) today announced it has entered into a multi-year supply agreement with Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH). The agreement gives LabCorp expanded rights to use Illumina next-generation sequencing (NGS) and microarray equipment and supplies to develop, validate and introduce laboratory-developed tests to clinicians in the United States and Canada.
Help employers find you! Check out all the jobs and post your resume.